Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,594,440 | $1,306,729 | $1,171,826 | $712,985 |
| - Cash | $836,197 | $50,409 | $52,240 | $131,678 |
| + Debt | $1,199,769 | $865,545 | $37,731 | $818,806 |
| Enterprise Value | $3,958,012 | $2,121,865 | $1,157,317 | $1,400,113 |
| Revenue | $510,672 | $502,400 | $640,313 | $544,483 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Gross Profit | $121,070 | $123,459 | $8,400 | $238,862 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| EBITDA | -$1,156,955 | -$63,121 | -$1,840,490 | $140,791 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |
| Net Income | -$1,315,005 | -$246,487 | -$2,146,318 | $47,312 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| % Growth | -690.8% | 89.7% | -3,250% | – |
| Operating Cash Flow | $42,896 | $65,114 | $205,187 | -$56,735 |
| Capital Expenditures | -$94,961 | -$16,161 | -$601,657 | -$59,275 |
| Free Cash Flow | -$52,065 | $48,953 | -$396,470 | -$116,010 |